A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence.
about
A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence.Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice.Baseline characteristics of patients predicting suitability for rapid naltrexone induction.Low-dose memantine attenuated methadone dose in opioid-dependent patients: a 12-week double-blind randomized controlled trial.Memantine improves buprenorphine/naloxone treatment for opioid dependent young adultsBuprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone.The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence.Retention in medication-assisted treatment for opiate dependence: A systematic review.Do specific NMDA receptor subunits act as gateways for addictive behaviors?A novel non-opioid protocol for medically supervised opioid withdrawal and transition to antagonist treatment.Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine.Sex Differences in Regional Brain Glucose Metabolism Following Opioid Withdrawal and Replacement.Advances in the delivery of buprenorphine for opioid dependence.Effect of ceftriaxone and topiramate treatments on naltrexone-precipitated morphine withdrawal and glutamate receptor desensitization in the rat locus coeruleus.Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies.
P2860
Q33556479-0986837B-31DF-4538-87AC-D66963009F54Q35090939-0220DDE2-8191-49CE-A7C6-8DEF16027C57Q35834292-C3530182-2FDB-45CC-91C6-0A25FBB5B5F5Q36294085-3FB708C5-BAA2-4370-A5E3-0B21DDD524A7Q36297525-3302D9FF-C124-45B3-84D9-200287A43EAFQ36394429-71D1312F-9040-47EC-A917-D160EEA7601CQ37621846-FD91C759-E544-4654-8AFB-D8F70AC052EFQ38025454-8F29A184-DEDC-41E4-880F-443D11B1788AQ38607448-94FE6648-8C02-444E-ABB2-8B9618188B9FQ38814541-09B6A4EB-90F7-4C45-B872-639F263697B5Q43061611-D3E45BF3-2CF5-4295-BA3B-02F9110B2CB5Q44342511-6F9C9028-8E8E-41DC-AE88-DC1D9670EF00Q44344766-5EE70D81-5671-46C6-91F0-3C2D1DEDC567Q45946172-D3BC9FDD-9C43-4B68-BE96-26228276E3F2Q48273821-04F8BC4F-486E-4472-A80C-7C9FC932268AQ52317035-4CE62FD2-CE3F-4E02-B693-DD5E6608E33F
P2860
A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A placebo controlled trial of ...... trexone for opioid dependence.
@ast
A placebo controlled trial of ...... trexone for opioid dependence.
@en
type
label
A placebo controlled trial of ...... trexone for opioid dependence.
@ast
A placebo controlled trial of ...... trexone for opioid dependence.
@en
prefLabel
A placebo controlled trial of ...... trexone for opioid dependence.
@ast
A placebo controlled trial of ...... trexone for opioid dependence.
@en
P2093
P2860
P1476
A placebo controlled trial of ...... trexone for opioid dependence.
@en
P2093
Edward V Nunes
Frances R Levin
John J Mariani
Kenneth M Carpenter
Maria A Sullivan
Wendy Y Cheng
Wilfrid N Raby
P2860
P356
10.1016/J.DRUGALCDEP.2011.05.019
P50
P577
2011-06-28T00:00:00Z